Authors:
Yu, ST
Cao, WQ
Kashireddy, P
Meyer, K
Jia, YZ
Hughes, DE
Tan, YJ
Feng, JC
Yeldandi, AV
Rao, MS
Costa, RH
Gonzalez, FJ
Reddy, JK
Citation: St. Yu et al., Human peroxisome proliferator-activated receptor alpha (PPAR alpha) supports the induction of peroxisome proliferation in PPAR alpha-deficient mouse liver, J BIOL CHEM, 276(45), 2001, pp. 42485-42491
Authors:
Wilson, IW
Schiff, CL
Hughes, DE
Somerville, SC
Citation: Iw. Wilson et al., Quantitative trait loci analysis of powdery mildew disease resistance in the Arabidopsis thaliana accession Kashmir-1, GENETICS, 158(3), 2001, pp. 1301-1309
Authors:
Bowen, D
Southerland, WM
Johnson, DH
Hawkins, M
Hughes, DE
Citation: D. Bowen et al., Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells, CANCER DET, 24(5), 2000, pp. 452-458
Authors:
Shipman, CM
Vanderkerken, K
Rogers, MJ
Lippitt, JM
Asosingh, K
Hughes, DE
Van Camp, B
Russell, RGG
Croucher, PI
Citation: Cm. Shipman et al., The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma, BR J HAEM, 111(1), 2000, pp. 283-286
Authors:
Bowen, D
Johnson, DH
Southerland, WM
Hughes, DE
Hawkins, M
Citation: D. Bowen et al., Selectivity in human breast cancer and human bone marrow using trimetrexate in combination with 5-fluorouracil, ANTICANC R, 19(5B), 1999, pp. 3837-3840
Authors:
Bowen, D
Johnson, DH
Southerland, WM
Hughes, DE
Hawkins, M
Citation: D. Bowen et al., 5-fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity inhuman bone marrow, ANTICANC R, 19(2A), 1999, pp. 985-988
Authors:
Fisher, JE
Rogers, MJ
Halasy, JM
Luckman, SP
Hughes, DE
Masarachia, PJ
Wesolowski, G
Russell, RGG
Rodan, GA
Reszka, AA
Citation: Je. Fisher et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, P NAS US, 96(1), 1999, pp. 133-138